Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
KCTD7 encodes a member of the potassium channel tetramerization domain-containing protein family. Additionally we are shipping Potassium Channel Tetramerisation Domain Containing 7 Proteins (9) and many more products for this protein.
Showing 10 out of 28 products:
KCTD7 expression hyperpolarizes the cell membrane and reduces the excitability of transfected neurons in patch clamp experiments.
KCTD7 has an impact on K+ fluxes, neurotransmitter synthesis and neuronal function, and that malfunction of the encoded protein may lead to progressive myoclonus epilepsy.
reviews the phenotype of progressive myoclonic epilepsy associated with KCTD7 mutations [review]
This study identified that novel KCTD7 mutation in patients with progressive myoclonus epilepsy with ataxia.
The KCTD7 gene, previously associated with progressive myoclonus epilepsies (PMEs) in a single inbred family, was screened for mutations in 18 Turkish PME (show CSTB Antibodies) patients.
this study clearly demonstrates that KCTD7 mutations also cause a rare, infantile-onset NCL (show CLN5 Antibodies) subtype designated as CLN14.
We found a C to T mutation in exon 2 of the potassium channel (show KCNAB2 Antibodies) tetramerization domain containing 7 gene(KCTD7)in a progressive myoclonic epilepsy family affecting a highly conserved segment of the predicted protein changing an arginine codon to a stop.
This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.
BTB/POZ domain-containing protein KCTD7
, potassium channel tetramerisation domain containing 7